Verb Surgical
About
About Verb Surgical
Verb Surgical was established by Johnson & Johnson and Verily to develop a connected surgical platform combining robotics, advanced instruments, visualisation and data analytics. The programme aimed to connect robotic assistance with preoperative information, intraoperative guidance and post-procedure learning through one digital system.
Johnson & Johnson agreed to acquire Verily’s remaining interest in 2019 and brought Verb fully into its medical-device organisation. The work became part of Johnson & Johnson MedTech’s wider digital-surgery programme, including development that contributed to the Ottava robotic-surgery system. Verb Surgical no longer operates as an independent joint venture.
Timeline
Events
- 2019-12-20 - Acquisition - Johnson & Johnson agrees to acquire Verily's Verb Surgical stake
The transaction covered Verily's remaining stake after the companies' multi-year surgical-robotics collaboration. Johnson & Johnson expected the acquisition to close in the first half of 2020, subject to antitrust clearance and customary conditions.
Source - 2015-12-10 - Partnership - Johnson & Johnson and Verily form Verb Surgical
Johnson & Johnson announced Verb Surgical's formation on December 10, 2015, following an earlier Ethicon-Google Life Sciences collaboration. Ethicon and Verily contributed intellectual property, in-process research assets and operating expertise to the new company. Verb's planned platform combined robotics, surgical instrumentation, visualization, machine learning, analytics and connectivity.
Source
Notes
Profile notes
- Verb Surgical's standalone programme ended inside Johnson & Johnson's broader robotic-surgery effort
reviewed 2026-07-19 - Verb Surgical began as a Verily-Johnson & Johnson joint venture. Johnson & Johnson later took full control and folded the work into its surgical-robotics organisation rather than continuing Verb as an independent commercial platform.
Source
Relations
Relationships
- Johnson & Johnson
Acquired By - Johnson & Johnson agreed to acquire Verily's remaining stake in Verb Surgical.